Peters S, Regan MM, Paz-Ares LG, Reck M, et al. Treatment-Free Survival Over 6 Years of Follow-up in Patients With Metastatic Non-small Cell Lung Cancer Treated With First-Line Nivolumab Plus Ipilimumab Versus Chemotherapy in CheckMate 227 Part 1. J Thorac Oncol 2025 Jun 3:S1556-0864(25)00749.
PMID: 40473108